Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Capital Expenditures: 2013-2022

Historic Capital Expenditures for vTv Therapeutics (VTVT) over the last 8 years, with Dec 2022 value amounting to $21,000.

  • vTv Therapeutics' Capital Expenditures was N/A to $18,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $128,000, marking a year-over-year change of. This contributed to the annual value of $21,000 for FY2022, which is N/A change from last year.
  • Latest data reveals that vTv Therapeutics reported Capital Expenditures of $21,000 as of FY2022, which was down 70.00% from $70,000 recorded in FY2019.
  • In the past 5 years, vTv Therapeutics' Capital Expenditures ranged from a high of $70,000 in FY2019 and a low of $5,000 during FY2018.
  • For the 1-year period, vTv Therapeutics' Capital Expenditures averaged around $21,000, with its median value being $21,000 (2022).
  • As far as peak fluctuations go, vTv Therapeutics' Capital Expenditures crashed by 91.23% in 2018, and later surged by 1,300.00% in 2019.
  • Yearly analysis of 3 years shows vTv Therapeutics' Capital Expenditures stood at $5,000 in 2018, then soared by 1,300.00% to $70,000 in 2019, then reached $21,000 in 2022.